𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC) : Results of a phase II study

✍ Scribed by Samy Louafi; Valérie Boige; Michel Ducreux; Luminita Bonyhay; Touraj Mansourbakht; Thierry de Baere; Amani Asnacios; Laurent Hannoun; Thierry Poynard; Julien Taïeb

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
105 KB
Volume
109
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus oxaliplatin (GEMOX) com
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma : Results of a multicenter phase 2 study
✍ Amani Asnacios; Laetitia Fartoux; Olivier Romano; Chloe Tesmoingt; Samy Louafi S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract ## BACKGROUND. The authors conducted a phase 2 trial of the antiepidermal growth factor receptor (EGFR) monoclonal antibody cetuximab in combination with the gemcitabine plus oxaliplatin (GEMOX) regimen in patients with documented progressive hepatocellular carcinoma (HCC). ## METHODS

A phase II trial of gemcitabine in patie
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma
✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili